DRKS00025255已完成不适用
Safety of SARS-CoV-2 vaccination during pregnancy (Covid-19)– Collection and analysis of pregnancy course data by the Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie - SARS-CoV-2 PregVac
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- Female
入选标准
- •Prospectively followed pregnancy courses with completed follow-up
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Effects of taking the COVID-19 vaccine in pregnancyCTRI/2021/11/037974Dept Of Obstetrics And Gynecology247
招募中
不适用
Prevalence of SARS-CoV-2 (COVID-19) in pregnancy and at delivery in Franconia and Thyringia, GermanyU07.1COVID-19, virus identifiedDRKS00022088niversitätsfrauenklinik Erlangen2,650
尚未招募
不适用
Survey to Assess Potential Acceptance of COVID 19 Vaccine in Pregnant and Lactating WomeCTRI/2021/04/032615A
进行中（未招募）
1 期
Vaccination against COVID-19 in Pregnant and Lactating Women in BelgiumVaccine responses to COVID19 vaccines administered in pregnant andlactating womenEUCTR2021-000440-22-BEniversiteit Antwerpen420
已完成
不适用
Safety of the new H1N1 influenza vaccine in pregnancynew influenza A(H1N1), spontaneous abortion, preeclampsia, preterm birth, intrauterine growth restriction, congenital disordersDRKS00000318Paul-Ehrlich-Institut PEIAbteilung Sicherheit von Arzneimitteln und Medizinprodukten1,652